Figure 4.

Effects of competitor peptides on thrombin clotting time. Diluted citrated human plasma was recalcified in the presence of thrombin and increasing concentrations of competitor peptides identified to the right of each line (either HCII 1-75 or HCII 54-75 (panel A) or sulfo-Hir 54-65 or Hir 55-65 (panel B)). The mean ± the SD of 3 independent experiments is shown.

Boyle et al. BMC Biochemistry 2013 14:6   doi:10.1186/1471-2091-14-6
Download authors' original image